Therapist-guided and self-guided internet-delivered behavioural activation for adolescents with depression: a randomised feasibility trial.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
26 12 2022
Historique:
entrez: 26 12 2022
pubmed: 27 12 2022
medline: 29 12 2022
Statut: epublish

Résumé

Access to effective treatments for adolescents with depression needs to improve. Few studies have evaluated behavioural activation (BA) for adolescent depression, and none remotely delivered BA. This study explored the feasibility and acceptability of therapist-guided and self-guided internet-delivered BA (I-BA) in preparation for a future randomised controlled trial (RCT). A single-blinded randomised controlled feasibility trial. A specialist outpatient clinic in Sweden. Thirty-two adolescents with mild-to-moderate major depression, aged 13-17 years. Ten weeks of therapist-guided I-BA or self-guided I-BA, or treatment as usual (TAU). Both versions of I-BA included parental support. TAU included referral to usual care within child and youth psychiatry or primary care. Feasibility measures included study take-up, participant retention, acceptability, safety and satisfaction. The primary outcome measure was the blinded assessor-rated Children's Depression Rating Scale, Revised. The primary endpoint was the 3-month follow-up. 154 adolescents were screened and 32 were randomised to therapist-guided I-BA (n=11), self-guided I-BA (n=10) or TAU (n=11). Participant retention was acceptable, with two drop-outs in TAU. Most participants in TAU had been offered interventions by the primary endpoint. The mean number of completed chapters (total of 8) for adolescents was 7.5 in therapist-guided I-BA and 5.4 in self-guided I-BA. No serious adverse events were recorded. Satisfaction was acceptable in both I-BA groups. Following an intent-to-treat approach, the linear mixed-effects model revealed that both therapist-guided and self-guided I-BA (Cohen's d=2.43 and 2.23, respectively), but not TAU (Cohen's d=0.95), showed statistically significant changes on the primary outcome measure with large within-group effect sizes. Both therapist-guided and self-guided I-BA are acceptable and potentially efficacious treatments for adolescents with depression. It is feasible to conduct a large-scale RCT to establish the efficacy and cost-effectiveness of I-BA versus TAU. ClinicalTrials.gov Registry (NCT04117789).

Identifiants

pubmed: 36572500
pii: bmjopen-2022-066357
doi: 10.1136/bmjopen-2022-066357
pmc: PMC9806095
doi:

Banques de données

ClinicalTrials.gov
['NCT04117789']

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e066357

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: DM-C reports personal fees from UpToDate, which was not involved in this work.

Références

J Couns Psychol. 2008 Oct;55(4):473-484
pubmed: 22017554
Behav Res Ther. 2016 Jan;76:47-56
pubmed: 26649465
Behav Cogn Psychother. 2018 Mar;46(2):182-194
pubmed: 28756787
JAMA Psychiatry. 2021 Sep 1;78(9):943-944
pubmed: 34160570
Internet Interv. 2018 May 02;13:8-15
pubmed: 30206513
Arch Gen Psychiatry. 1983 Nov;40(11):1228-31
pubmed: 6639293
Depress Anxiety. 2005;22(3):130-7
pubmed: 16175563
BJPsych Open. 2018 Jun 26;4(4):199-207
pubmed: 29988969
Clin Psychol Rev. 2004 Sep;24(5):583-616
pubmed: 15325746
Internet Interv. 2021 Nov 02;26:100479
pubmed: 34804812
Psychosom Med. 2011 May;73(4):323-35
pubmed: 21536837
J Am Acad Child Adolesc Psychiatry. 2011 Jan;50(1):32-45
pubmed: 21156268
Lancet Child Adolesc Health. 2018 Nov;2(11):792-801
pubmed: 30241993
J Clin Psychiatry. 2010 Mar;71(3):313-26
pubmed: 20331933
Clin Psychol Rev. 2010 Aug;30(6):608-20
pubmed: 20677369
J Child Psychol Psychiatry. 2012 Nov;53(11):1109-17
pubmed: 22574736
Int J Environ Res Public Health. 2020 Nov 10;17(22):
pubmed: 33182711
J Am Acad Child Adolesc Psychiatry. 2015 Jan;54(1):37-44.e2
pubmed: 25524788
J Affect Disord. 2015 Apr 1;175:152-67
pubmed: 25618002
BMJ. 2015 Mar 04;350:h824
pubmed: 25739880
Behav Ther. 2011 Dec;42(4):726-39
pubmed: 22036000
Annu Rev Clin Psychol. 2011;7:1-38
pubmed: 21275642
Pharm Stat. 2008 Apr-Jun;7(2):93-106
pubmed: 17351897
Psychol Bull. 2006 Jan;132(1):132-49
pubmed: 16435960
Pediatrics. 2010 Jan;125(1):75-81
pubmed: 20008426
Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):745-64
pubmed: 23252357
Psychiatr Clin North Am. 2012 Mar;35(1):1-14
pubmed: 22370487
Psychiatry (Edgmont). 2007 Jul;4(7):28-37
pubmed: 20526405
J Consult Clin Psychol. 2008 Dec;76(6):909-22
pubmed: 19045960
Qual Life Res. 2010 Dec;19(10):1487-500
pubmed: 20668950
Behav Cogn Psychother. 2019 Sep;47(5):559-572
pubmed: 30871650
JAMA Psychiatry. 2021 Apr 1;78(4):361-371
pubmed: 33471111
Behav Res Ther. 2015 Apr;67:1-18
pubmed: 25727678
J Consult Clin Psychol. 2006 Aug;74(4):658-70
pubmed: 16881773
J Adolesc Health. 2022 Mar;70(3):496-499
pubmed: 34663534
Eur Child Adolesc Psychiatry. 2019 Apr;28(4):427-441
pubmed: 29476253
J Med Internet Res. 2019 Nov 1;21(11):e13393
pubmed: 31682572
Educ Psychol Meas. 2016 Feb;76(1):64-87
pubmed: 29795857
Clin Psychol Rev. 2016 Dec;50:1-10
pubmed: 27668988
Psychol Assess. 2012 Dec;24(4):833-45
pubmed: 22329531
Child Psychiatry Hum Dev. 2020 Jun;51(3):453-460
pubmed: 32006302
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246
Lancet Psychiatry. 2017 Feb;4(2):120-127
pubmed: 28087201
Arch Gen Psychiatry. 1997 Aug;54(8):744-8
pubmed: 9283510
J Clin Child Adolesc Psychol. 2016;45(3):291-304
pubmed: 25602170
Child Adolesc Ment Health. 2017 May;22(2):61-68
pubmed: 32680323
J Child Psychol Psychiatry. 2019 Aug;60(8):828-847
pubmed: 30775782
Eval Program Plann. 1979;2(3):197-207
pubmed: 10245370
J Consult Clin Psychol. 1996 Apr;64(2):295-304
pubmed: 8871414
JAMA. 1999 May 12;281(18):1707-13
pubmed: 10328070
J Clin Child Adolesc Psychol. 2017 Jan-Feb;46(1):11-43
pubmed: 27870579
PLoS One. 2020 Mar 25;15(3):e0230623
pubmed: 32210463
Psychol Methods. 2009 Mar;14(1):43-53
pubmed: 19271847
Int J Environ Res Public Health. 2022 Apr 28;19(9):
pubmed: 35564759
J Affect Disord. 2011 May;130(3):395-404
pubmed: 21112639
Psychol Psychother. 2017 Dec;90(4):770-796
pubmed: 28299896
Eur Psychiatry. 2010 Nov;25(7):396-401
pubmed: 20541372
J Am Acad Child Adolesc Psychiatry. 1999 Jan;38(1):56-63
pubmed: 9893417

Auteurs

Rebecca Grudin (R)

Centre for Psychiatry Research,Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden rebecca.grudin@ki.se.
Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.

Johan Ahlen (J)

Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
The Centre for Epidemiology and Community Medicine, Region Stockholm, Stockholm, Sweden.

David Mataix-Cols (D)

Centre for Psychiatry Research,Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.

Fabian Lenhard (F)

Centre for Psychiatry Research,Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Eva Henje (E)

Department of Clinical Science, Child and Adolescent Psychiatry, Umeå Universitet, Umea, Sweden.

Cecilia Månsson (C)

Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.

Hanna Sahlin (H)

Centre for Psychiatry Research,Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.

Maria Beckman (M)

Centre for Psychiatry Research,Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.

Eva Serlachius (E)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.

Sarah Vigerland (S)

Centre for Psychiatry Research,Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH